Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the analgesic efficacy of intravenous (IV) oliceridine
administered as needed (PRN) compared with placebo in patients with moderate to severe acute
pain after abdominoplasty.